San Diego-based Viking Therapeutics marked alone as a serious competitor while in the weight loss drug current market in February right after revealing promising information from a mid-phase demo of experimental drug VK2735, which proposed it rivaled—and outperformed—Novo and Lilly drugs when provided like a weekly injection and in March the co